$8.90

+0.04 (+0.45%)

After Hours: $9.12 (+0.21, +2.42%)

Weekly Expected Move ±5.4%

$7 $8 $8 $9 $9

NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Neutral · Power 42 · $1.9B mcap · 216M float · 1.21% daily turnover · Short 33% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

32.0 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: -0.5% · 5Y Avg: -1.3%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NEOG has No discernible competitive edge (32.0/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. Negative ROIC of -0.5% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Low

$10

Avg Target

$10

High

Based on 3 analyst ratings (12 mo)

Analyst Recommendations

Strong Buy: 0Buy: 4Hold: 6Sell: 1Strong Sell: 0

Rating Summary

ConsensusHold

Avg Target$9.50

Analysts3

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-01-12	Piper Sandler	David Westenberg	$6	$10	+4	+7.9%	$9.27
2026-01-09	Guggenheim	—	Initiated	$12	—	+23.6%	$9.71
2025-10-16	Piper Sandler	David Westenberg	$5	$6	+2	+9.2%	$5.95
2025-04-22	Piper Sandler	David Westenberg	$18	$5	-12	+5.3%	$4.75
2024-08-06	Piper Sandler	David Westenberg	$17	$18	+0	+8.4%	$16.15
2022-12-14	Piper Sandler	David Westenberg	$14	$17	+3	+10.7%	$15.35
2022-10-09	Piper Sandler	David Westenberg	Initiated	$14	—	+10.4%	$12.68

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NEOG receives an overall rating of C-. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-04-09	C	C-
2026-01-15	D+	C
2026-01-08	C	D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 18 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NEOG scores highest in Value (50/100) and lowest in Profitability (14/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

0.22

Distress Zone

Piotroski F-Score

4/9

✗ ✓ ✗ ✓ ✗ ✗ ✗ ✓ ✓

Beneish M-Score

-3.84

Unlikely Manipulator

Ohlson O-Score

-7.33

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

BB-

Score: 38.6/100

Trend: Deteriorating

Earnings Quality

—

OCF/NI: -0.11x

Accruals: -16.7%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NEOG scores 0.22, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NEOG scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NEOG's score of -3.84 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NEOG's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NEOG receives an estimated rating of BB- (score: 38.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-3.21x

PEG

0.02x

P/S

2.24x

P/B

0.93x

P/FCF

75.60x

P/OCF

19.64x

EV/EBITDA

-4.80x

EV/Revenue

2.37x

EV/EBIT

-3.78x

EV/FCF

121.17x

Earnings Yield

-46.36%

FCF Yield

1.32%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NEOG currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.976

NI / EBT

Interest Burden

1.120

EBT / EBIT

EBIT Margin

-0.626

EBIT / Rev

Asset Turnover

0.220

Rev / Assets

Equity Multiplier

1.533

Assets / Equity

ROE

-23.1%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NEOG's ROE of -23.1% is driven by Asset Turnover (0.220), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.98 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Assessment

Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$8.90

Median 1Y

$6.84

5th Pctile

$3.22

95th Pctile

$14.53

Ann. Volatility

46.2%

25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
John E. Adent (Former) President & Chief Executive Officer	$810,000	$1,800,000	$6,824,891
David H. Naemura Chief Financial Officer & Chief Operating Officer	$571,500	$836,400	$2,680,181
Douglas E. Jones Chief Operating Officer (Retired)	$464,322	$720,000	$2,276,461
Amy M. Rocklin Chief Legal & Compliance Officer	$447,694	$520,000	$1,767,767

CEO Pay Ratio

51:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $6,824,891

Avg Employee Cost (SGA/emp): $134,469

Employees: 2,974

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

2,974

+1.9% YoY

Revenue / Employee

$300,828

Rev: $894,661,000

Profit / Employee

$-367,197

NI: $-1,092,044,000

SGA / Employee

$134,469

Avg labor cost proxy

R&D / Employee

$7,090

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	9.0%	7.8%	7.9%	7.3%	6.3%	5.6%	4.2%	-1.9%	-1.6%	-1.1%	-1.3%	0.6%	0.1%	-0.3%	-0.7%	-15.2%	-15.5%	-41.9%	-40.0%	-23.1%	-23.11%
ROA	8.2%	7.1%	7.2%	6.6%	5.7%	5.1%	3.8%	-1.7%	-1.4%	-0.8%	-1.0%	0.4%	0.1%	-0.2%	-0.5%	-10.5%	-10.7%	-27.3%	-26.1%	-15.1%	-15.08%
ROIC	15.6%	13.0%	13.5%	12.3%	10.6%	9.3%	6.8%	3.5%	5.0%	0.8%	1.1%	7.4%	1.6%	1.4%	1.2%	1.1%	1.1%	0.8%	0.1%	-0.5%	-0.48%
ROCE	10.2%	8.7%	8.9%	8.2%	7.1%	6.6%	4.9%	2.0%	3.0%	0.8%	1.1%	1.7%	1.7%	1.4%	1.0%	-9.8%	-9.9%	-32.5%	-30.7%	-16.9%	-16.86%
Gross Margin	46.1%	45.3%	46.8%	46.4%	44.8%	46.4%	47.0%	48.9%	49.5%	50.9%	51.0%	50.9%	50.5%	47.9%	39.8%	38.8%	39.4%	30.8%	34.4%	47.5%	47.48%
Operating Margin	13.5%	15.9%	16.9%	9.6%	5.0%	12.9%	4.6%	-3.3%	7.2%	9.7%	8.4%	9.1%	5.1%	7.4%	4.0%	7.4%	5.4%	-3.5%	-7.6%	-2.4%	-2.39%
Net Margin	11.5%	12.4%	13.3%	8.3%	4.2%	10.7%	3.9%	-18.2%	3.8%	2.3%	0.7%	-1.5%	-0.9%	-2.3%	-5.8%	-2.0%	-5.0%	-2.7%	17.4%	-7.1%	-7.09%
EBITDA Margin	18.5%	20.4%	21.4%	14.4%	10.1%	17.7%	9.4%	5.7%	19.6%	22.3%	21.3%	19.3%	18.7%	17.6%	15.1%	-1.9%	16.9%	-2.6%	42.7%	10.4%	10.42%
FCF Margin	12.8%	11.6%	11.4%	10.7%	9.8%	8.3%	-1.0%	-8.0%	-11.4%	-3.0%	-0.6%	1.8%	-1.5%	-8.3%	-13.7%	-10.2%	-4.9%	-5.2%	-0.4%	2.0%	1.95%
OCF Margin	18.8%	17.3%	16.2%	14.8%	13.5%	12.9%	5.8%	-0.9%	-4.1%	5.0%	8.5%	12.2%	10.7%	3.8%	-0.7%	2.0%	7.5%	6.5%	9.8%	7.5%	7.52%
ROE 3Y Avg	snapshot only																				-14.62%
ROE 5Y Avg	snapshot only																				-7.78%
ROA 3Y Avg	snapshot only																				-9.24%
ROIC 3Y Avg	snapshot only																				-3.25%
ROIC Economic	snapshot only																				-0.46%
Cash ROA	snapshot only																				1.92%
Cash ROIC	snapshot only																				2.32%
CROIC	snapshot only																				0.60%
NOPAT Margin	snapshot only																				-1.55%
Pretax Margin	snapshot only																				-70.14%
R&D / Revenue	snapshot only																				2.33%
SGA / Revenue	snapshot only																				46.75%
SBC / Revenue	snapshot only																				2.02%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	71.56	81.90	76.22	76.07	78.61	59.08	61.86	-224.69	-283.92	-165.53	-188.65	311.81	2377.60	-302.35	-158.84	-6.45	-4.49	-1.16	-1.20	-2.16	-3.206
P/S Ratio	9.77	10.64	9.71	8.63	7.50	5.41	4.24	5.78	5.31	4.60	5.45	4.00	4.01	3.08	4.10	3.36	2.41	1.42	1.41	1.48	2.242
P/B Ratio	6.07	5.93	5.63	5.16	4.59	3.22	2.54	4.11	4.31	1.21	1.60	1.17	1.19	0.91	1.19	0.98	0.69	0.61	0.60	0.63	0.928
P/FCF	76.33	91.70	85.42	80.70	76.58	65.44	-414.00	-72.67	-46.49	-153.08	-962.10	222.17	-273.13	-37.14	-29.80	-32.98	-49.17	-27.44	-395.81	75.60	75.600
P/OCF	51.90	61.49	59.79	58.15	55.45	41.95	73.46	—	—	92.27	64.13	32.72	37.59	82.03	—	164.14	31.91	21.84	14.34	19.64	19.638
EV/EBITDA	42.14	47.85	43.91	42.23	40.87	29.49	27.22	51.60	37.07	36.29	35.69	22.77	23.04	20.18	27.70	-12.24	-9.21	-2.18	-2.29	-4.80	-4.804
EV/Revenue	9.01	9.83	8.93	7.87	6.77	4.69	3.53	5.18	4.78	5.40	6.16	4.71	4.71	3.88	4.90	4.17	3.22	2.30	2.29	2.37	2.367
EV/EBIT	53.16	61.20	56.40	55.94	56.65	41.10	41.53	175.04	126.68	130.83	119.58	57.06	59.41	58.90	102.28	-8.87	-6.71	-1.94	-2.02	-3.78	-3.779
EV/FCF	70.39	84.71	78.57	73.64	69.05	56.74	-344.28	-65.10	-41.88	-179.45	-1087.21	261.61	-320.96	-46.73	-35.67	-40.86	-65.75	-44.35	-644.34	121.17	121.167
Earnings Yield	1.4%	1.2%	1.3%	1.3%	1.3%	1.7%	1.6%	-0.4%	-0.4%	-0.6%	-0.5%	0.3%	0.0%	-0.3%	-0.6%	-15.5%	-22.2%	-85.9%	-83.6%	-46.4%	-46.36%
FCF Yield	1.3%	1.1%	1.2%	1.2%	1.3%	1.5%	-0.2%	-1.4%	-2.2%	-0.7%	-0.1%	0.5%	-0.4%	-2.7%	-3.4%	-3.0%	-2.0%	-3.6%	-0.3%	1.3%	1.32%
PEG Ratio	snapshot only																				0.023
EV/OCF	snapshot only																				31.475
EV/Gross Profit	snapshot only																				6.221
Shareholder Yield	snapshot only																				0.00%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	11.08	11.03	11.03	11.03	11.03	8.05	8.05	8.05	8.05	4.03	4.03	4.03	4.03	3.82	3.82	3.82	3.82	3.32	3.32	3.32	3.316
Quick Ratio	9.12	9.16	9.16	9.16	9.16	6.48	6.48	6.48	6.48	3.11	3.11	3.11	3.11	2.59	2.59	2.59	2.59	2.22	2.22	2.22	2.219
Debt/Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.44	0.44	0.44	0.441
Net Debt/Equity	-0.47	-0.45	-0.45	-0.45	-0.45	-0.43	-0.43	-0.43	-0.43	0.21	0.21	0.21	0.21	0.23	0.23	0.23	0.23	0.38	0.38	0.38	0.378
Debt/Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.26	0.26	0.26	0.265
Debt/EBITDA	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	7.34	5.65	4.73	4.73	5.10	5.61	-2.91	-2.86	-0.97	-1.03	-2.10	-2.104
Net Debt/EBITDA	-3.56	-3.95	-3.83	-4.05	-4.46	-4.52	-5.51	-6.00	-4.08	5.33	4.11	3.43	3.43	4.14	4.55	-2.36	-2.32	-0.83	-0.88	-1.81	-1.807
Interest Coverage	—	—	—	—	1755.54	1720.20	1289.69	0.91	0.72	0.61	0.64	1.05	1.01	0.83	0.59	-5.83	-5.94	-14.82	-14.46	-8.33	-8.334
Equity Multiplier	1.10	1.09	1.09	1.09	1.09	1.12	1.12	1.12	1.12	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.66	1.66	1.66	1.663
Cash Ratio	snapshot only																				0.741
Debt Service Coverage	snapshot only																				-6.556
Cash to Debt	snapshot only																				0.141
FCF to Debt	snapshot only																				0.019
Defensive Interval	snapshot only																				292.7 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.60	0.55	0.57	0.59	0.60	0.55	0.56	0.66	0.75	0.30	0.33	0.33	0.34	0.20	0.20	0.20	0.20	0.22	0.22	0.22	0.220
Inventory Turnover	2.66	2.59	2.68	2.77	2.85	2.55	2.56	2.99	3.34	3.25	3.58	3.55	3.57	2.86	2.97	3.15	3.28	2.96	2.99	2.87	2.869
Receivables Turnover	5.38	5.31	5.52	5.70	5.83	5.51	5.55	6.59	7.53	6.50	7.27	7.26	7.35	5.67	5.59	5.60	5.55	5.48	5.43	5.39	5.394
Payables Turnover	10.78	10.23	10.60	10.93	11.25	9.71	9.77	11.40	12.75	7.49	8.24	8.16	8.21	5.78	6.01	6.37	6.63	6.91	6.99	6.71	6.705
DSO	68	69	66	64	63	66	66	55	48	56	50	50	50	64	65	65	66	67	67	68	67.7 days
DIO	137	141	136	132	128	143	142	122	109	112	102	103	102	128	123	116	111	123	122	127	127.2 days
DPO	34	36	34	33	32	38	37	32	29	49	44	45	44	63	61	57	55	53	52	54	54.4 days
Cash Conversion Cycle	171	174	168	163	158	172	171	145	129	120	108	108	108	129	127	124	122	137	137	140	140.4 days
Fixed Asset Turnover	snapshot only																				2.471
Operating Cycle	snapshot only																				194.9 days
Cash Velocity	snapshot only																				6.824
Capital Intensity	snapshot only																				3.912

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	7.5%	12.0%	14.4%	16.1%	14.3%	12.5%	9.0%	25.4%	40.1%	56.0%	73.0%	45.7%	28.9%	12.4%	-0.7%	-0.5%	-2.5%	-3.2%	-2.8%	-3.7%	-3.67%
Net Income	4.3%	2.4%	2.3%	-5.4%	-20.1%	-20.7%	-41.3%	-1.3%	-1.3%	-1.5%	-1.7%	1.7%	1.1%	58.8%	11.5%	-41.4%	-310.9%	-114.9%	-43.3%	-26.5%	-26.54%
EPS	3.0%	0.7%	0.9%	-6.8%	-20.7%	-20.5%	-41.2%	-1.1%	-1.1%	-1.2%	-1.4%	1.7%	1.1%	58.8%	11.4%	-41.4%	-310.3%	-114.7%	-43.3%	-26.2%	-26.19%
FCF	-7.1%	-12.0%	-15.4%	-23.8%	-12.5%	-19.8%	-1.1%	-1.9%	-2.6%	-1.6%	4.3%	1.3%	83.4%	-2.1%	-23.1%	-6.6%	-2.3%	39.6%	97.5%	1.2%	1.18%
EBITDA	8.4%	6.1%	6.4%	0.3%	-11.5%	-12.8%	-30.5%	-32.5%	9.2%	45.8%	1.3%	2.0%	1.0%	45.2%	1.7%	-2.6%	-2.7%	-6.3%	-6.5%	-39.4%	-39.37%
Op. Income	11.4%	9.8%	9.8%	-1.2%	-17.6%	-21.0%	-44.3%	-67.5%	-47.2%	-36.0%	17.8%	2.5%	1.3%	84.8%	16.3%	-30.5%	-26.4%	-56.9%	-91.2%	-1.3%	-1.31%
OCF Growth	snapshot only																				2.53%
Asset Growth	snapshot only																				-24.29%
Equity Growth	snapshot only																				-34.12%
Debt Growth	snapshot only																				0.70%
Shares Change	snapshot only																				0.27%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	4.9%	5.5%	6.5%	7.1%	7.6%	8.4%	8.5%	14.8%	19.8%	25.3%	29.2%	28.5%	27.3%	25.4%	23.2%	22.0%	20.8%	19.3%	18.6%	11.8%	11.76%
Revenue 5Y	7.8%	7.8%	8.1%	8.1%	7.8%	7.8%	7.3%	10.5%	13.1%	15.6%	17.9%	17.5%	17.6%	17.4%	17.0%	17.0%	16.7%	16.4%	15.8%	15.2%	15.23%
EPS 3Y	0.7%	-1.7%	-3.0%	-5.6%	-8.5%	-7.8%	-15.8%	—	—	—	—	-54.2%	-76.7%	—	—	—	—	—	—	—	—
EPS 5Y	9.9%	9.3%	9.5%	6.5%	2.5%	1.0%	-5.3%	—	—	—	—	-38.7%	-58.6%	—	—	—	—	—	—	—	—
Net Income 3Y	1.9%	-1.2%	-2.2%	-4.5%	-7.4%	-7.1%	-15.1%	—	—	—	—	-42.0%	-70.6%	—	—	—	—	—	—	—	—
Net Income 5Y	11.2%	10.7%	10.8%	7.8%	3.6%	2.0%	-4.5%	—	—	—	—	-29.0%	-52.1%	—	—	—	—	—	—	—	—
EBITDA 3Y	2.6%	2.2%	3.1%	1.0%	-2.0%	-2.5%	-9.0%	-11.4%	1.6%	10.5%	19.5%	26.6%	25.4%	22.6%	17.7%	—	—	—	—	—	—
EBITDA 5Y	7.5%	7.0%	7.3%	5.3%	1.9%	0.6%	-3.9%	-6.1%	0.8%	6.3%	11.9%	15.8%	16.0%	14.4%	12.1%	—	—	—	—	—	—
Gross Profit 3Y	4.0%	4.7%	6.1%	6.9%	7.5%	8.2%	8.2%	15.2%	21.3%	27.4%	32.4%	32.3%	31.2%	29.1%	24.4%	20.4%	16.9%	11.0%	9.0%	4.1%	4.06%
Gross Profit 5Y	7.0%	7.0%	7.6%	7.6%	7.2%	7.2%	6.7%	10.3%	13.4%	16.7%	19.6%	19.6%	20.0%	19.2%	17.5%	15.8%	14.1%	11.1%	9.9%	10.8%	10.80%
Op. Income 3Y	2.1%	1.9%	3.1%	-0.1%	-4.2%	-4.9%	-14.2%	-30.5%	-21.5%	-17.8%	-10.3%	3.6%	0.6%	-2.2%	-8.6%	-7.8%	-3.1%	-20.1%	-50.5%	—	—
Op. Income 5Y	5.9%	5.6%	6.5%	3.7%	-0.2%	-2.0%	-8.4%	-19.6%	-14.3%	-11.8%	-6.4%	2.3%	1.7%	0.4%	-2.8%	-4.1%	-3.6%	-15.1%	-40.6%	—	—
FCF 3Y	9.6%	4.1%	4.8%	-2.0%	1.0%	-3.9%	—	—	—	—	—	-38.4%	—	—	—	—	—	—	—	—	—
FCF 5Y	18.7%	20.8%	10.2%	11.4%	6.7%	-0.9%	—	—	—	—	—	-21.9%	—	—	—	—	—	—	—	-24.6%	-24.61%
OCF 3Y	11.2%	5.5%	6.0%	0.1%	2.0%	2.1%	-24.6%	—	—	-21.8%	-3.6%	6.5%	5.3%	-24.6%	—	-36.9%	-0.6%	-5.0%	41.5%	—	—
OCF 5Y	17.2%	18.1%	10.1%	11.1%	5.8%	2.5%	-12.2%	—	—	-9.9%	3.3%	8.6%	8.6%	-11.5%	—	-23.6%	-3.4%	-7.5%	-0.1%	-6.6%	-6.56%
Assets 3Y	14.7%	14.2%	14.2%	14.2%	14.2%	12.6%	12.6%	12.6%	12.6%	78.8%	78.8%	78.8%	78.8%	70.3%	70.3%	70.3%	70.3%	51.4%	51.4%	51.4%	51.37%
Assets 5Y	15.2%	15.3%	15.3%	15.3%	15.3%	13.4%	13.4%	13.4%	13.4%	49.1%	49.1%	49.1%	49.1%	45.6%	45.6%	45.6%	45.6%	34.0%	34.0%	34.0%	34.00%
Equity 3Y	15.4%	14.5%	14.5%	14.5%	14.5%	11.6%	11.6%	11.6%	11.6%	62.9%	62.9%	62.9%	62.9%	55.2%	55.2%	55.2%	55.2%	32.7%	32.7%	32.7%	32.65%
Book Value 3Y	14.1%	13.9%	13.6%	13.1%	13.2%	10.8%	10.8%	-12.7%	-12.0%	28.5%	28.5%	28.6%	28.9%	23.1%	23.1%	23.1%	23.1%	5.1%	5.1%	33.2%	33.22%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.95	0.94	0.94	0.92	0.93	0.92	0.92	0.79	0.72	0.67	0.63	0.75	0.81	0.83	0.79	0.88	0.90	0.87	0.78	0.81	0.814
Earnings Stability	0.76	0.65	0.59	0.40	0.09	0.01	0.07	0.40	0.51	0.55	0.64	0.63	0.71	0.72	0.79	0.54	0.55	0.50	0.51	0.77	0.772
Margin Stability	0.98	0.99	0.99	0.99	0.99	0.99	0.99	0.99	0.98	0.97	0.96	0.96	0.96	0.96	0.96	0.95	0.93	0.89	0.88	0.90	0.898
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Earn. Growth Consistency	0.50	0.50	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earnings Persistence	0.98	0.99	0.99	0.98	0.92	0.92	0.83	0.20	0.20	0.20	0.20	0.20	0.20	0.50	0.50	0.20	0.20	0.50	0.50	0.50	0.500
Earnings Smoothness	0.96	0.98	0.98	0.94	0.78	0.77	0.48	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	-0.02	-0.02	-0.01	-0.02	-0.03	-0.02	-0.04	-0.09	-0.09	-0.07	-0.07	-0.02	-0.02	-0.03	-0.02	-0.14	-0.15	-0.52	-0.50	-0.22	-0.217
Gross Margin Trend	0.00	-0.01	-0.00	-0.00	-0.01	-0.00	-0.00	0.01	0.02	0.03	0.04	0.04	0.04	0.02	-0.01	-0.05	-0.08	-0.13	-0.13	-0.09	-0.094
FCF Margin Trend	-0.01	-0.02	-0.03	-0.04	-0.04	-0.05	-0.14	-0.21	-0.23	-0.13	-0.06	0.00	-0.01	-0.11	-0.13	-0.07	0.02	0.00	0.07	0.06	0.062
Sustainable Growth Rate	9.0%	7.8%	7.9%	7.3%	6.3%	5.6%	4.2%	—	—	—	—	0.6%	0.1%	—	—	—	—	—	—	—	—
Internal Growth Rate	9.0%	7.6%	7.8%	7.1%	6.1%	5.3%	4.0%	—	—	—	—	0.4%	0.1%	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.38	1.33	1.27	1.31	1.42	1.41	0.84	0.36	2.19	-1.79	-2.94	9.53	63.24	-3.69	0.26	-0.04	-0.14	-0.05	-0.08	-0.11	-0.110
FCF/OCF	0.68	0.67	0.70	0.72	0.72	0.64	-0.18	8.52	2.79	-0.60	-0.07	0.15	-0.14	-2.21	20.24	-4.98	-0.65	-0.80	-0.04	0.26	0.260
FCF/Net Income	snapshot only																				-0.029
CapEx/Revenue	6.0%	5.7%	4.9%	4.1%	3.7%	4.6%	6.8%	7.0%	7.3%	8.0%	9.1%	10.4%	12.1%	12.1%	13.1%	12.3%	12.4%	11.7%	10.2%	5.6%	5.57%
CapEx/Depreciation	snapshot only																				0.417
Accruals Ratio	-0.03	-0.02	-0.02	-0.02	-0.02	-0.02	0.01	-0.01	0.02	-0.02	-0.04	-0.04	-0.04	-0.01	-0.00	-0.11	-0.12	-0.29	-0.28	-0.17	-0.167
Sloan Accruals	snapshot only																				-0.037
Cash Flow Adequacy	snapshot only																				1.351

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	0.0%	0.0%	—	—	—	—	—	—	—	—
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—	0.0%	—	—	—	—	—	—	—	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	0.0%	0.0%	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-0.6%	-0.7%	-0.6%	-0.7%	-0.5%	-0.3%	-0.3%	-0.1%	-0.0%	-0.0%	-0.0%	-0.0%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.4%	-0.3%	-0.3%	-0.25%
Total Shareholder Return	-0.6%	-0.7%	-0.6%	-0.7%	-0.5%	-0.3%	-0.3%	-0.1%	-0.0%	-0.0%	-0.0%	-0.0%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.4%	-0.3%	-0.3%	-0.25%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.81	0.81	0.80	0.81	0.80	0.80	0.81	8.63	1.25	1.04	0.98	3.56	-6.12	0.66	0.75	0.94	0.95	0.96	0.97	0.98	0.976
Interest Burden (EBT/EBIT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	-0.10	-0.40	-0.65	-0.57	0.04	-0.00	-0.24	-0.72	1.17	1.17	1.07	1.07	1.12	1.120
EBIT Margin	0.17	0.16	0.16	0.14	0.12	0.11	0.08	0.03	0.04	0.04	0.05	0.08	0.08	0.07	0.05	-0.47	-0.48	-1.19	-1.13	-0.63	-0.626
Asset Turnover	0.60	0.55	0.57	0.59	0.60	0.55	0.56	0.66	0.75	0.30	0.33	0.33	0.34	0.20	0.20	0.20	0.20	0.22	0.22	0.22	0.220
Equity Multiplier	1.10	1.10	1.10	1.10	1.10	1.11	1.11	1.11	1.11	1.38	1.38	1.38	1.38	1.45	1.45	1.45	1.45	1.53	1.53	1.53	1.533

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$0.57	$0.56	$0.57	$0.53	$0.45	$0.45	$0.34	$-0.07	$-0.06	$-0.11	$-0.12	$0.05	$0.01	$-0.04	$-0.11	$-2.20	$-2.24	$-5.03	$-4.81	$-2.77	$-2.77
Book Value/Share	$6.75	$7.78	$7.77	$7.77	$7.77	$8.23	$8.23	$4.03	$4.10	$14.48	$14.45	$14.48	$14.47	$14.52	$14.51	$14.50	$14.49	$9.54	$9.54	$9.53	$9.66
Tangible Book/Share	$5.11	$5.71	$5.70	$5.70	$5.70	$5.91	$5.91	$2.89	$2.94	$-2.81	$-2.81	$-2.81	$-2.81	$-2.32	$-2.32	$-2.32	$-2.32	$-1.86	$-1.86	$-1.86	$-1.86
Revenue/Share	$4.19	$4.34	$4.51	$4.65	$4.76	$4.89	$4.93	$2.86	$3.33	$3.80	$4.24	$4.25	$4.29	$4.27	$4.21	$4.21	$4.17	$4.12	$4.09	$4.05	$4.00
FCF/Share	$0.54	$0.50	$0.51	$0.50	$0.47	$0.40	$-0.05	$-0.23	$-0.38	$-0.11	$-0.02	$0.08	$-0.06	$-0.35	$-0.58	$-0.43	$-0.20	$-0.21	$-0.01	$0.08	$0.19
OCF/Share	$0.79	$0.75	$0.73	$0.69	$0.64	$0.63	$0.28	$-0.03	$-0.14	$0.19	$0.36	$0.52	$0.46	$0.16	$-0.03	$0.09	$0.31	$0.27	$0.40	$0.30	$0.32
Cash/Share	$3.20	$3.53	$3.53	$3.52	$3.52	$3.53	$3.53	$1.73	$1.76	$1.13	$1.13	$1.13	$1.13	$0.79	$0.79	$0.79	$0.79	$0.59	$0.59	$0.59	$0.73
EBITDA/Share	$0.90	$0.89	$0.92	$0.87	$0.79	$0.78	$0.64	$0.29	$0.43	$0.57	$0.73	$0.88	$0.88	$0.82	$0.75	$-1.44	$-1.46	$-4.34	$-4.08	$-1.99	$-1.99
Debt/Share	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$4.15	$4.14	$4.15	$4.14	$4.18	$4.18	$4.18	$4.18	$4.20	$4.20	$4.20	$4.20
Net Debt/Share	$-3.19	$-3.52	$-3.51	$-3.51	$-3.51	$-3.52	$-3.52	$-1.72	$-1.75	$3.01	$3.01	$3.01	$3.01	$3.39	$3.39	$3.39	$3.39	$3.61	$3.61	$3.60	$3.60

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.218
Altman Z-Prime	snapshot only																				0.178
Piotroski F-Score	6	5	6	6	5	7	6	4	3	4	4	7	6	4	3	2	2	3	3	4	4
Beneish M-Score	-2.58	-2.39	-2.42	-2.46	-2.45	-2.50	-2.42	-2.27	-2.14	-0.94	-0.93	-0.92	-0.99	-2.38	-2.20	-2.67	-2.79	-4.02	-4.27	-3.84	-3.845
Ohlson O-Score	snapshot only																				-7.326
Net-Net WC	snapshot only																				$-3.66
EVA	snapshot only																				$-299105010.00

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BB-
Credit Score	92.21	91.98	92.57	92.04	95.80	95.55	91.31	66.97	65.48	41.74	47.53	49.41	47.72	37.75	42.58	41.85	36.76	32.98	32.12	38.58	38.580
Credit Grade	snapshot only																				13
Credit Trend	snapshot only																				-3.273
Implied Spread (bps)	snapshot only																				550.000
Industry Credit Rank	snapshot only																				34
Sector Credit Rank	snapshot only																				30

NEOG NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet